Omega Therapeutics Inc (OMGA)
0.786
+0.01
(+1.29%)
USD |
NASDAQ |
Nov 22, 16:00
0.765
-0.02
(-2.67%)
After-Hours: 20:00
Omega Therapeutics Profit Margin (Quarterly): -629.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -629.6% |
| June 30, 2024 | -764.1% |
| March 31, 2024 | -852.9% |
| December 31, 2023 | -2.04K% |
| September 30, 2023 | -2.68K% |
| June 30, 2023 | -3.91K% |
| Date | Value |
|---|---|
| March 31, 2023 | -4.90K% |
| December 31, 2022 | -4.19K% |
| September 30, 2022 | -4.34K% |
| June 30, 2022 | -5.44K% |
| March 31, 2022 | -7.52K% |
| December 31, 2021 | -14.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.48K%
Minimum
Dec 2021
-629.6%
Maximum
Sep 2024
-4.31K%
Average
-4.05K%
Median
Profit Margin (Quarterly) Benchmarks
| Moderna Inc | 0.70% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -171.4% |
| Return on Assets | -39.43% |
| Return on Invested Capital | -120.9% |
| Operating Margin (Quarterly) | -628.6% |
| Return on Net Operating Assets | -60.25% |